Hospital-acquired Antibiotic-resistant Fungal Infections Being Tackled by Torrance, CA Non-profit
Monday, April 15, 2019
Researchers at LA BioMed in Torrance, CA have been working to create a therapeutic vaccine for 2 years to fight infections caused by Candida auris. The lab studies have been most encouraging. With its resistance to anti-fungal drugs, a vaccine is likely the best way to combat the antibiotic-resistant nature of this emerging and deadly pathogen.
Drs. Ashraf Ibrahim and Jack Edwards, in conjunction with the LA BioMed spinoff company NovaDigm Therapeutics, are developing a vaccine specifically designed to combat these infections, largely hospital acquired, and very often fatal. Recent media coverage documents the necessity of exactly this type of non-antibiotic approach.